| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis (NCT02757729) | Amorepacific Corporation | 2015-10-01 |
| Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis (NCT02595073) | Sun Pharmaceutical Industries, Inc. | 2015-09-04 |
| Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis (NCT02525094) | MedImmune LLC | 2015-08-15 |
| To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin) (NCT02601703) | Glenmark Pharmaceuticals Ltd. India | 2015-08-01 |
| Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children (NCT02519556) | Casa Espirita Terra de Ismael | 2015-08-01 |
| Natural History and Genetics of Food Allergy and Related Conditions (NCT02504853) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-29 |
| Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis (NCT02908360) | Nantes University Hospital | 2015-07-10 |
| An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) (NCT02496546) | LEO Pharma | 2015-07-01 |
| Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients (NCT02144142) | University of California, San Diego | 2015-07-01 |
| Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis (NCT02475447) | Tioga Pharmaceuticals | 2015-07-01 |
| Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis (NCT03676036) | DS Biopharma | 2015-06-01 |
| Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis (NCT02589392) | Galderma R&D | 2015-05-29 |
| A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis (NCT02424253) | Ziarco Pharma Ltd | 2015-05-18 |
| A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis (NCT02340234) | Hoffmann-La Roche | 2015-05-01 |
| Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis (NCT02456480) | Maruho Co., Ltd. | 2015-05-01 |
| The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel (NCT01686048) | Meir Medical Center | 2015-04-01 |
| A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema) (NCT02407756) | Regeneron Pharmaceuticals | 2015-03-31 |
| A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD) (NCT02395133) | Regeneron Pharmaceuticals | 2015-03-25 |
| Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis (NCT03361215) | University Hospital Schleswig-Holstein | 2015-03-16 |
| Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis (NCT02369432) | Centre Hospitalier Universitaire de Besancon | 2015-02-20 |
| Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic Dermatitis (NCT02945683) | Noos S.r.l. | 2015-02-01 |
| A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) (NCT02376049) | LEO Pharma | 2015-02-01 |
| Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis (NCT02791308) | Actavis Inc. | 2015-02-01 |
| Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (NCT02347176) | MedImmune LLC | 2015-01-23 |
| The Natural History of Atopic Disease in Thai Children and Association With Atopic March (NCT02532920) | Mahidol University | 2015-01-01 |
| A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families (NCT02067234) | Seton Healthcare Family | 2015-01-01 |
| Oral DS107 in Moderate to Severe Atopic Dermatitis (NCT02211417) | Dignity Sciences Ltd. | 2015-01-01 |
| Validation of the Short-term Antimicrobial Action of Transplanted Bacteria (NCT01959113) | University of California, San Diego | 2015-01-01 |
| A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects (NCT02334787) | Otsuka Pharmaceutical Co., Ltd. | 2015-01-01 |
| Preventing Atopic Dermatitis and ALLergies in Children (NCT02449850) | Oslo University Hospital | 2014-12-14 |
| Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis (NCT02324972) | Aquinox Pharmaceuticals (Canada) Inc. | 2014-12-01 |
| Role of Anti-IgE in Severe Childhood Eczema (NCT02300701) | Guy's and St Thomas' NHS Foundation Trust | 2014-12-01 |
| A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis (NCT02379910) | AnaMar AB | 2014-11-01 |
| Cognitive Behavior Therapy for Atopic Dermatitis (NCT02302625) | Karolinska Institutet | 2014-11-01 |
| Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis (NCT02289989) | Rutgers, The State University of New Jersey | 2014-11-01 |
| Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema (NCT02224950) | University of Minnesota | 2014-11-01 |
| Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence (NCT02193230) | Nantes University Hospital | 2014-10-14 |
| Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (NCT02260986) | Regeneron Pharmaceuticals | 2014-09-01 |
| Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD) (NCT02210780) | Regeneron Pharmaceuticals | 2014-08-05 |
| A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis (NCT02345928) | Janssen Research & Development, LLC | 2014-08-05 |
| Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (NCT02031445) | Celsus Therapeutics PLC | 2014-08-01 |
| Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD) (NCT02365246) | Universitaire Ziekenhuizen KU Leuven | 2014-08-01 |
| 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis (NCT02241174) | Makati Medical Center | 2014-07-01 |
| Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients (NCT02178215) | Mahidol University | 2014-07-01 |
| Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) (NCT02219633) | LEO Pharma | 2014-07-01 |
| Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic Dermatitis (NCT02103972) | Société des Produits Nestlé (SPN) | 2014-07-01 |
| Sebum Collection and Skin Barrier Function Analysis (NCT03112876) | University of California, Davis | 2014-06-27 |
| A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (NCT02068352) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-06-20 |
| The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants (NCT02401178) | Indonesia University | 2014-05-01 |
| Protopic Adherence and Efficacy in Korean Eczema Patient (NCT02126176) | Pusan National University Hospital | 2014-05-01 |
| Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution (NCT04651829) | Hôpital Armand Trousseau | 2014-05-01 |
| Pilot Tape Harvesting Study (NCT02125695) | Biogen | 2014-05-01 |
| Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis (NCT01996423) | Pontificia Universidad Catolica de Chile | 2014-04-01 |
| A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis (NCT02103725) | LEO Pharma | 2014-04-01 |
| Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen (NCT02073591) | Hyphens Pharma Pte Ltd | 2014-03-01 |
| The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis (NCT02594969) | University of California, Davis | 2014-01-01 |
| A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis (NCT02094235) | Organon and Co | 2014-01-01 |
| Bleach Bath Treatment of Adults With Atopic Dermatitis (NCT01996150) | University of Rochester | 2014-01-01 |
| Cesarean Section Study (NCT01992497) | Société des Produits Nestlé (SPN) | 2013-12-01 |
| Phase 2 Study of KHK4577 (NCT02004119) | Kyowa Kirin Co., Ltd. | 2013-11-01 |
| A Phase 2 Study of CIM331 for Atopic Dermatitis Patients (NCT01986933) | Chugai Pharmaceutical | 2013-11-01 |
| Open-label Study of Dupilumab in Patients With Atopic Dermatitis (NCT01949311) | Regeneron Pharmaceuticals | 2013-10-10 |
| Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis (NCT01941537) | Rockefeller University | 2013-10-01 |
| Effect of OC000459 on Moderate to Severe Atopic Dermatitis (NCT02002208) | Atopix Therapeutics, Ltd. | 2013-10-01 |
| A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis (NCT01993420) | Dermira, Inc. | 2013-10-01 |
| Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) (NCT01927705) | Kang Stem Biotech Co., Ltd. | 2013-09-01 |
| The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis (NCT01936194) | Mead Johnson Nutrition | 2013-09-01 |
| Photocil (Topical) for the Treatment of Atopic Dermatitis (NCT01992172) | Applied Biology, Inc. | 2013-08-01 |
| Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus (NCT01905631) | The Center for Clinical and Cosmetic Research | 2013-07-01 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis (NCT01808157) | Creabilis SA | 2013-07-01 |
| A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema (NCT01826630) | Shari L Hand | 2013-07-01 |
| Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis. (NCT01785602) | Novartis Pharmaceuticals | 2013-06-01 |
| Topical Roflumilast in Adults With Atopic Dermatitis (NCT01856764) | AstraZeneca | 2013-06-01 |
| Assessing Risk of Food Insecurity Within Households of Children With Food Allergy (NCT01897506) | Arkansas Children's Hospital Research Institute | 2013-06-01 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis (NCT02583022) | Amorepacific Corporation | 2013-06-01 |
| Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis (NCT01859988) | Regeneron Pharmaceuticals | 2013-05-01 |
| Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream (NCT01850849) | LEO Pharma | 2013-05-01 |
| Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream (NCT02153762) | Icahn School of Medicine at Mount Sinai | 2013-04-01 |
| An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis (NCT01826461) | PreCision Dermatology, Inc. | 2013-03-01 |
| Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients (NCT01695707) | University of Rochester | 2013-03-01 |
| Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis (NCT01806662) | Rockefeller University | 2013-03-01 |
| PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases (NCT01805635) | Medical University of Lodz | 2013-02-01 |
| Platelet Activation in Chronic Inflammatory Skin Diseases (NCT01759693) | Meir Medical Center | 2013-02-01 |
| Emollients in the Management of Atopic Dermatitis (NCT01779258) | Pierre Fabre Medicament | 2013-02-01 |
| Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) (NCT01781663) | Kamedis Ltd. | 2013-02-01 |
| Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis (NCT01782703) | Northwestern University | 2013-01-01 |
| A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003) (NCT01732510) | Merck Sharp & Dohme LLC | 2012-12-21 |
| Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis (NCT01756898) | Daiichi Sankyo | 2012-11-28 |
| A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients (NCT01714245) | TopMD Skin Care, Inc. | 2012-11-01 |
| KM110329 in Adult Patients With Atopic Dermatitis (NCT01692093) | Kyunghee University Medical Center | 2012-09-01 |
| A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis (NCT01702181) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2012-08-01 |
| A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis (NCT01675232) | Yale University | 2012-07-01 |
| Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis (NCT01538342) | Centre Hospitalier Universitaire de Nice | 2012-07-01 |
| Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD) (NCT01639040) | Regeneron Pharmaceuticals | 2012-07-01 |
| Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis (NCT01577628) | Cosmetique Active International | 2012-06-01 |
| Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects (NCT02176551) | Fougera Pharmaceuticals Inc. | 2012-06-01 |
| Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects (NCT02176538) | Fougera Pharmaceuticals Inc. | 2012-06-01 |
| Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis (NCT01605708) | Regeneron Pharmaceuticals | 2012-06-01 |
| An Innovative Probiotic Product With Antiallergic Properties (NCT04738565) | Children's Memorial Health Institute, Poland | 2012-06-01 |
| Study to Determine the Pharmacokinetics of Product 0405 (NCT02176577) | Fougera Pharmaceuticals Inc. | 2012-06-01 |